A 3-month-old infant with ventricular septal defect (VSD) is… | 마이메르시 MyMerci
마이메르시 — 문제와 상세 해설까지 전부 무료 무료로 시작하기
Child Health
문제

A 3-month-old infant with ventricular septal defect (VSD) is admitted to the pediatric unit with signs of congestive heart failure. The infant is receiving digoxin and furosemide. Which nursing assessment finding requires the most immediate intervention?

해설
An apical pulse below 100 bpm in an infant on digoxin indicates potential toxicity, requiring immediate withholding of digoxin and physician notification. Other findings (HR 140, RR 50, weight gain 30g) are within normal ranges for a 3-month-old.
같은 주제 다음 문제A 2-year-old toddler with a history of ventricular septal defect (VSD) repair is brought t…

심화 해설

Understanding the Clinical Context

The infant in this scenario has a ventricular septal defect (VSD), a congenital heart defect causing a left-to-right shunt. This increases pulmonary blood flow, placing the infant at high risk for congestive heart failure (CHF). The prescribed medications, digoxin and furosemide, are standard therapy to improve cardiac contractility and reduce fluid overload. The core of this question is recognizing the critical adverse effect of digoxin and the nurse's responsibility in medication safety.

Analysis of Assessment Findings

The question asks for the finding requiring the most immediate intervention. This demands prioritizing based on the risk of life-threatening complications. Let's analyze each option.

In-depth Review of the Correct Answer (Option 3)

An apical pulse of 80 beats per minute in a 3-month-old infant is a critical finding. The normal resting heart rate for this age group is typically between 100 and 160 beats per minute. A heart rate of 80 bpm constitutes significant bradycardia. Digoxin has a narrow therapeutic index, and its most dangerous manifestation of toxicity is cardiac dysrhythmia, with bradycardia being a classic early sign in pediatric patients. The nurse's standard of practice is to withhold digoxin and notify the prescriber if the apical pulse is below a specified parameter, commonly 90-100 bpm in infants. Administering the medication in the presence of bradycardia could precipitate a more severe, potentially fatal, heart block. The provided research underscores the critical nature of therapeutic drug monitoring (TDM) for digoxin, as it evaluates the drug's concentration in relation to patient-specific factors like renal function and electrolytes, which directly influence toxicity risk . This finding demands withholding the drug and obtaining an immediate prescriber order, making it the highest priority.

Why the Other Options Are Less Immediate

- Option 1: A heart rate of 140 bpm in an awake and crying infant is within the expected range. Crying naturally elevates the heart rate. This is an expected finding, not an immediate emergency.
- Option 2: A respiratory rate of 50 breaths per minute with mild retractions is an expected finding in an infant with a VSD experiencing CHF. The left-to-right shunt causes pulmonary congestion, leading to tachypnea and increased work of breathing. While this requires ongoing monitoring and management with medications like furosemide, it does not represent an acute, new-onset crisis requiring withholding a medication in the same way digoxin toxicity does.
- Option 4: A weight gain of 30 grams in 24 hours with stable intake is a finding that requires careful monitoring for fluid retention, a hallmark of CHF. However, this is a subtle change that reflects the underlying disease process and response to therapy over time. It does not present an immediate threat of harm within the next few minutes, unlike the bradycardia that contraindicates the next dose of a critical medication. The study on digoxin TDM highlights the importance of monitoring renal function, as impaired clearance is a major contributor to toxicity, but the immediate actionable finding at the bedside is the heart rate itself .

임상 시나리오

Clinical Practice Guide: Administering Digoxin to an Infant with CHF

Scenario: A 3-month-old infant with VSD and CHF on digoxin and furosemide.

1. Pre-Administration Assessment
  • Apical Pulse Check: Auscultate the apical pulse for a full 60 seconds. The critical safety parameter is to withhold digoxin if the infant's pulse is below 90-100 bpm.
  • Signs of Toxicity: Assess for early signs beyond bradycardia, including vomiting, poor feeding, and lethargy. In older children, visual disturbances may be reported.
  • Electrolyte & Drug Review: Check recent potassium levels, as hypokalemia potentiates digoxin toxicity. Review concurrent medications, especially diuretics like furosemide which can cause potassium loss.
2. Immediate Intervention for Bradycardia (Pulse < 90-100 bpm)
  1. Withhold the Dose: Do not administer the scheduled digoxin.
  2. Notify the Prescriber Immediately: Report the heart rate, any other signs of toxicity, and recent lab values.
  3. Continuous Monitoring: Place the infant on a cardiorespiratory monitor to observe for worsening bradycardia or new arrhythmias.
3. Ongoing Monitoring and Family Education
  • Daily Weights: Monitor strict intake and output and daily weights on the same scale to assess fluid balance. A sudden increase may indicate worsening CHF.
  • Respiratory Status: Monitor respiratory rate, work of breathing, and oxygen saturation. Mild tachypnea and retractions are common with VSD and CHF.
  • Caregiver Teaching: Educate parents to always check the infant's pulse before giving digoxin at home. Instruct them to call the provider if the pulse is below the specified threshold, if the infant vomits a dose, or shows signs of illness. Emphasize safe storage of digoxin to prevent accidental poisoning.

핵심 개념

Merci NCLEX-RN Question Bank 3,445 문제 · 로그인 없이 바로 볼 수 있어요

마이메르시로 국가고시 완벽 대비

기출문제와 상세 해설을 무료로. 내 약점을 분석하고 진도를 관리하며 더 똑똑하게 공부하세요.

무료로 시작하기

학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요.